APA guidelines suggest that LAI antipsychotics be offered to patients with schizophrenia if they prefer such treatment or if they have a history of poor or uncertain adherence, within the context of a person-centered treatment plan that includes evidence-based nonpharmacologic and pharmacologic treatments for schizophrenia.
Learn more about the treatment of schizophrenia.
Medscape © 2021 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Ravinder N. Bhalla. Fast Five Quiz: Long-Acting Injectable Antipsychotics - Medscape - Aug 19, 2021.